摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tetrakis(μ-[N,N'-bis(2-phenylethyl)-2,6-pyridinedicarboxamidato])tetrapalladium(II) | 465512-19-0

中文名称
——
中文别名
——
英文名称
tetrakis(μ-[N,N'-bis(2-phenylethyl)-2,6-pyridinedicarboxamidato])tetrapalladium(II)
英文别名
——
tetrakis(μ-[N,N'-bis(2-phenylethyl)-2,6-pyridinedicarboxamidato])tetrapalladium(II)化学式
CAS
465512-19-0
化学式
C92H84N12O8Pd4
mdl
——
分子量
1911.43
InChiKey
NSSVKAAXDPGSME-UHFFFAOYSA-F
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Architectural formation of a conjugated bimetallic Pd(ii) complex via oxidative complexation and a tetracyclic Pd(ii) complex via self-assembling complexationElectronic supplementary information: experimental section and crystallography. Figs. S1–6. See http://www.rsc.org/suppdata/cc/b2/b203726m/
    摘要:
    1,4- 苯二胺与钯(II)络合物[(L1)Pd(MeCN)](H2L1 = N. N′-双(2-苯基乙基)-2,6-吡啶二甲酰胺)原位氧化络合,在一锅反应中获得了共轭同种金属钯(II)络合物[(L1)Pd(qd)Pd(L1)](qd = 醌二胺)、N′-双(2-苯基乙基)-2,6-吡啶二甲酰胺)进行原位氧化复配,而在没有额外配体的情况下,[(L1)Pd(MeCN)]会转化为酰胺桥接的大环四聚体[Pd(L1)]4。
    DOI:
    10.1039/b203726m
  • 作为产物:
    描述:
    (N,N'-bis(2-phenylethyl)-2,6-pyridinedicarboxamidato)(η1-acetonitrile)palladium(II)二氯甲烷 为溶剂, 以99%的产率得到tetrakis(μ-[N,N'-bis(2-phenylethyl)-2,6-pyridinedicarboxamidato])tetrapalladium(II)
    参考文献:
    名称:
    Architectural formation of a conjugated bimetallic Pd(ii) complex via oxidative complexation and a tetracyclic Pd(ii) complex via self-assembling complexationElectronic supplementary information: experimental section and crystallography. Figs. S1–6. See http://www.rsc.org/suppdata/cc/b2/b203726m/
    摘要:
    1,4- 苯二胺与钯(II)络合物[(L1)Pd(MeCN)](H2L1 = N. N′-双(2-苯基乙基)-2,6-吡啶二甲酰胺)原位氧化络合,在一锅反应中获得了共轭同种金属钯(II)络合物[(L1)Pd(qd)Pd(L1)](qd = 醌二胺)、N′-双(2-苯基乙基)-2,6-吡啶二甲酰胺)进行原位氧化复配,而在没有额外配体的情况下,[(L1)Pd(MeCN)]会转化为酰胺桥接的大环四聚体[Pd(L1)]4。
    DOI:
    10.1039/b203726m
点击查看最新优质反应信息

文献信息

  • Coordination properties towards palladium(II) of a tridentate dianionic ligand acting as a N- or a N,O-donor
    作者:Daniela Belli Dell’Amico、Fausto Calderazzo、Francesco Di Colo、Gianfranco Guglielmetti、Luca Labella、Fabio Marchetti
    DOI:10.1016/j.ica.2005.06.073
    日期:2006.1
    The new palladium(II) complex Pd[C5H3N-2,6-(CONPh)(2)](eta(1)-NCMe) (1), prepared from N,N'-diphenyl-2,6-pyridinedicarboxamide and Pd(OAC)(2) in acetonitrile, has been characterized via IR, H-1 NMR and single-crystal X-ray diffraction. In this compound the palladium centre is coordinated to three nitrogen donors of the anionic ligand and to the nitrogen atom of acetonitrile.Moreover, the already known Pd[C5H3N-2,6-(CONCH2CH2Ph)(2)](eta(1)-NCMe) (2) has been studied by H-1 NMR spectrometry and found to readily convert into the macrocyclic tetranuclear species 3, Pd[C5H3N-2,6-(CONCH2CH2Ph)(2)]}4 which has been isolated and characterized by IR, H-1 and C-13 H-1-(NMR)-N-13, H-1-C-13 HETCOR and mass spectrometry, as well as by single-crystal X-ray diffraction. In 3, of S-4 symmetry, each palladium atom is coordinated to the three nitrogen atoms of the anionic ligand, while the fourth coordination position is occupied by the amidato oxygen atom of an adjacent unit. This structure is apparently maintained in CDCl3 solution. The substitution reactions of acetonitrile in 2 with the ligands EEt2 (E = S, Se) afford Pd[C5H3N-2,6-(CONCH,CH,Ph)(2)](EEt2) (4, E = S; 5, E = Se); these products can also be obtained by the addition of EEt2 to 3, as shown by means of H-1- and, in the case of E = Se, Se-77H-1} NMR spectroscopy in CDCl3 solution. These results show that the Pd-O bonds of the tetranuclear species are readily broken by weakly coordinating ligands such as acetonitrile and diethylchalcogenides. Nevertheless, we are dealing with equilibrium reactions and, in some solvents, 3 can be obtained from 2, 4 or 5 being favoured by its low solubility. (c) 2005 Elsevier B.V. All rights reserved.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)